Exploring the Link Between Antidepressants and Cataracts: What You Need to Know

Link Between Antidepressants and Cataract Development

Overview of Cataracts

Cataracts are characterized by a partial or complete clouding of the lens of the eye and are recognized as a leading cause of vision loss globally. The increasing prevalence of cataracts poses a significant challenge to public health. Various factors, including age, steroid use, high blood pressure, and smoking, have been identified as contributing to the risk of developing cataracts.

Research on Antidepressants and Cataract Risk

Recent studies have focused on the potential connection between antidepressant use and cataract formation. Epidemiological research suggests that there may be an association between the use of antidepressants and an increased risk of cataracts; however, the findings across these studies are often conflicting and inconsistent. To address this, a systematic review and meta-analysis were conducted, with the results published in BMC Ophthalmology.

Methodology of the Meta-Analysis

The systematic review identified seven studies that investigated the relationship between antidepressant use and cataract risk. This meta-analysis included data from 447,672 cases and 1,510,391 controls, revealing a positive association between the use of various classes of antidepressants, including selective serotonin reuptake inhibitors (SSRIs), selective serotonin and norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants, and the risk of cataract development.

Proposed Mechanisms for the Association

The authors of the meta-analysis proposed several mechanisms that may explain how antidepressant use could lead to cataract development:

1. Increased serotonin levels have been linked to lens opacity in animal studies.
2. High serotonin levels are observed in the fluid surrounding the eyes of glaucoma and cataract patients.
3. Tricyclic antidepressants are associated with heightened sensitivity to ultraviolet light, which may contribute to cortical cataract formation.

Need for Further Research

Despite the findings, the meta-analysis highlighted considerable heterogeneity among the included studies and the limited number of research articles available. Therefore, further large-scale and well-designed studies are necessary to validate these findings and to better understand the relationship between antidepressant use and cataract risk.

Reference

Fu, Yana, et al. “Antidepressants use and risk of cataract development: a systematic review and meta-analysis.” BMC Ophthalmology 18.1 (2018): 31. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801704/. Last accessed 26th Feb 2018.